基于结构的分子查和动态模拟针对VEGFR-2的植物化合物:一种针对乳头甲状腺癌的新治疗方法

相关实验视频

Updated: May 8, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.2K

Shuai Wang1, Lingqian Zhang2, Wenjun Zhang2

  • 1Department of General Surgery, Xinqiao Hospital, The Army Medical University, Chongqing, China.

Frontiers in pharmacology
|June 24, 2025
PubMed
概括

这项研究确定了天然化合物17.3.1.7.8和BMC_0005作为血管内皮生长因子受体-2 (VEGFR-2) 的潜在抑制剂. 这些化合物显示出通过向瘤血管生成来治疗乳头甲状腺癌 (PTC) 的前景.

关键词:
在VEGFR-2的基础上,血管新生是因为血管新生.分子动态模拟分子动态模拟皮囊甲状腺癌是甲状腺癌.虚拟的药物查是虚拟的药物查.

更多相关视频

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.3K
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

7.8K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...